Th2 cells and GATA-3 in asthma: New insights into the regulation of airway inflammation

Journal of Clinical Investigation

Volumn 104, Issue 8, 1999, Pages 985-993

  Ray, Anuradha ^a   Cohn, Lauren ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; TRANSCRIPTION FACTOR;

AIRWAY; ASTHMA; HUMAN; IMMUNOPATHOGENESIS; INFLAMMATION; INTERFERON PRODUCTION; LYMPHOCYTE DIFFERENTIATION; NOTE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

EID: 0032750835     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI8204     Document Type: Note

References (64)

1. Wills-Karp, M. 1999. Immunologic basis of antigen-induced airway induced hyperresponsiveness. Annu. Rev. Immunol. 17:255-281.
2. Cohn, L., Homer, R.J., Marinov, A., Rankin, J., and Bottomly, K. 1997. Induction of airway mucus production by T helper 2 (Th2) cells: a critical role for interleukin 4 in cell recruitment but not mucus production. J. Exp. Med. 186:1737-1747.
3. Cohn, L., et al. 1999. Th2-induced airway mucus production is dependent on IL-4Ralpha, but not on eosinophils. J. Immunol. 162:6178-6183.
4. Corrigan, C.J., Hartnell, A., and Kay, A.B. 1988, T lymphocyte activation in acute severe asthma. Lancet. 1:1129-1132.
5. Walker, C., et al. 1992. Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am. Rev. Respir. Dis. 146:109-115.
6. Cher, D., and Mosmann, T. 1987. Two types of murine helper T cell clone. II. Delayed type hypersensitivity is mediated by Th1 clones. J. Immunol. 138:3688-3694.
7. Kim, J., Woods, A., Becker-Dunn, E., and Bottomly, K. 1985. Distinct functional phenotypes of cloned Ia-restricted helper T cells. J. Exp. Med. 162:188-201.
8. Mosmann, T.R., Cherwinski, H., Bond, M.W., Giedlin, M.A., and Coffman, R.L. 1986. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136:2348-2337.
9. Killar, L., MacDonald, G., West, J., Woods, A., and Bottomly, K. 1987. Cloned Ia restricted T cells that do not produce IL4/BSF-1 fail to help antigen specific B cells. J. Immunol. 138:1674-1679.
10. Barner, M., Mohrs, M., Brombacher, F., and Kopf, M. 1998. Differences between IL-4R alpha-deficient and IL-4-deficient mice reveal a role for IL-13 in the regulation of Th2 responses. Curr. Biol. 8:669-672.
11. Coffman, R.L., Seymour, B.W.P., Hudak, S., Jackson, J., and Rennick, D. 1989. Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice. Science. 245:308-310.
12. Nakajima, H., et al. 1992. CD4+ T-lymphocytes and interleukin-5 mediate antigen-induced eosinophil infiltration into mouse trachea. Am. Rev. Respir. Dis. 146:374-377.
13. Robinson, D.S., et al. 1992. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N. Engl. J. Med. 326:298-304.
14. Humbert, M., et al. 1997. Elevated expression of messenger ribonucleic acid encoding IL-13 in the bronchial mucosa of atopic and nonatopic subjects with asthma. J. Allergy Clin. Immunol. 99:657-665.
15. Kotsimbos, T.C., Ernst, P., and Hamid, Q.A. 1996. Interleukin-13 and interleukin-4 are coexpressed in atopic asthma. Proc. Assoc. Am. Physicians. 108:368-373.
16. Holtzman, M.J., Sampath, D., Castro, M., Look, D.C., and Jayaraman, S. 1996. The one-two of T helper cells: does interferon-gamma knock out the Th2 hypothesis for asthma? Am. J. Respir. Cell. Mol. Biol. 14:316-318.
17. Cembrzynska-Nowak, M., Szklarz, E., Inglot, A.D., and Teodorczyk-Injevan, J.A. 1993. Elevated release of tumor necrosis factor-alpha and interferon-gamma by bronchoalveolar leukocytes from patients with bronchial asthma. Am. Rev. Respir. Dis. 147:291-295.
18. Krug, N., et al. 1996. T cell cytokine profile evaluated at the single cells level in BAL and blood in allergic asthma. Am. J. Respir. Cell. Mol. Biol. 14:319-326.
19. Kelly, E.A., Rodriguez, R.R., Busse, W.W., and Jarjour, N.N. 1997. The effect of segmental bronchoprovocation with allergen on airway lymphocyte function. Am. J. Respir. Crit. Care Med. 156:1421-1428.
20. Renz, H., et al. 1993. Specific V beta T cell subsets mediate the immediate hypersensitivity response to ragweed allergen. J. Immunol. 151:1907-1917
21. Cohn, L., Tepper, J.S., and Bottomly, K. 1998. IL-4-independent induction of airway hyperresponsiveness by Th2, but not Th1, cells. J. Immunol. 161:3813-3816.
22. Grunig, G., et al. 1998. Requirement for IL-13 independently of IL-4 in experimental asthma. Science. 282:2261-2263.
23. Wills-Karp, M., et al. 1998. Interleukin-13: central mediator of allergic asthma [see comments]. Science. 282:2258-2261.
24. Coffman, R.L., Mocci, S., and O'Garra, A. 1999. The stability and reversibility of Th1 and Th2 populations. Curr. Top. Microbiol. Immunol. 238:1-12.
25. Zuany-Amorim, C., et al. 1998. Requirement for gammadelta T cells in allergic airway inflammation. Science. 280:1265-1267.
26. Kung, T.T., et al. 1995. Mast cells modulate allergic pulmonary eosinophilia in mice. Am. J. Respir. Cell. Mol. Biol. 12:404-409.
27. Stumbles, P.A., et al. 1998. Resting respiratory tract dendritic cells preferentially stimulate T helper cell type 2 (Th2) responses and require obligatory cytokine signals for induction of Th1 immunity. J. Exp. Med. 188:2019-2031.
28. Rissoan, M.C., et al. 1999. Reciprocal control of T helper cell and dendritic cell differentiation [see comments]. Science. 283:1183-1186.
29. Constant, S.L., and Bottomly, K. 1997. Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches. Annu. Rev. Immunol. 15:297-322.
30. Comoy, E., et al. 1999. Do allergens induce type-2 immune responses? Int. Arch. Allergy. Immunol. 118:399-402.
31. Agarwal, S., and Rao, A. 1998. Modulation of chromatin structure regulates cytokine gene expression during T cell differentiation. Immunity. 9:765-775.
32. Kaplan, M.H., and Grusby, M.J. 1998. Regulation of T helper cell differentiation by STAT molecules. J. Leukoc. Biol. 64:2-5.
33. Palmer-Crocker, R.L., Hughes, C.C., and Pober, J.S. 1996. IL-4 and IL-13 activate the JAK2 tyrosine kinase and Stat6 in cultured human vascular endothelial cells through a common pathway that does not involve the gamma c chain. J. Clin. Invest. 98:604-609.
34. Ho, I.C., et al. 1991. Human GATA-3: a lineage-restricted transcription factor that regulates the expression of the T cell receptor alpha gene. EMBO J. 10:1187-1192.
35. Orkin, S.H. 1995. Hematopoiesis: how does it happen? Curr. Opin. Cell Biol. 7:870-877.
36. Pandolfi, P., et al. 1995. Target disruption of the GATA-3 gene causes severe abnormalities in the nervous system and in fetal liver hematopoiesis. Nat. Genet. 11:40-44.
37. Ting, C.-N., Olson, M.C., Barton, K.P., and Leiden, J.M. 1996. Transcription factor GATA-3 is required for development of the T-cell lineage. Nature. 384:474-478.
38. Hattori, N., Kawamoto, H., Fujimoto, S., Kuno, K., and Katsura, Y. 1996. Involvement of transcription factors TCF-1 and GATA-3 in the initiation of the earliest step of T cell development in the thymus. J. Exp. Med. 184:1137-1147.
39. Zhang, D.-H., Cohn, L., Ray, P., Bottomly, K., and Ray, A. 1997 Transcription factor GATA-3 is differentially expressed in Th1 and Th2 cells and controls Th2-specific expression of the interleukin-5 gene. J. Biol. Chem. 272:21597-21603.
40. Ouyang, W., et al. 1998. Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism. Immunity. 9:745-755.
41. Siegel, M.D., Zhang, D.-H., Ray, P., and Ray, A. 1995. Activation of the interleukin-5 promoter by cAMP in murine EL-4 cells requires the GATA-3 and CLE0 elements. J. Biol. Chem. 270:24548-24555.
42. Zheng, W., and Flavell, R.A. 1997. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell. 89:587-596.
43. Zhang, D.-H., Yang, L., and Ray, A. 1998. Differential responsiveness of the interleukin-5 (IL-5) and IL-4 genes to transcription factor GATA-3. J. Immunol. 161:3817-3821.
44. Ranganath, S., et al. 1998. GATA-3-dependent enhancer activity in IL-4 gene regulation. J. Immunol. 161:3822-3826.
45. Nakamura, Y., et al. 1999. Gene expression of the GATA-3 transcription factor is increased in atopic asthma. J. Allergy Clin. Immunol. 103:215-222.
46. Zhang, D.H., et al. 1999. Inhibition of allergic inflammation in a murine model of asthma by expression of a dominant-negative mutant of GATA-3. Immunity. In press.
47. Ho, I.-C., Hodge, M.R., Rooney, J.W., and Glimcher, L.H. 1996. The proto-oncogene c-maf is responsible for tissue-specific expression of interleukin-4. Cell. 85:973-983.
48. Kim, J.I., Ho, I.-C., Grusby, M.J., and Glimcher, L.H. 1999. The transcription factor c-Maf controls the production of IL-4 but not other Th2 cytokines. Immunity. 10:745-751.
49. Rao, A., Luo, C., and Hogan, P.G. 1997. Transcription factors of the NFAT family: regulation and function. Annu. Rev. Immunol. 15:707-747.
50. Glimcher, L.H., and Singh, H. 1999. Transcription factors in lymphocyte development - T and B cells get together. Cell. 96:13-23.
51. Yang, L., et al. 1998. Essential role of nuclear factor kB in the induction of eosinophilia in allergic airway inflammation. J. Exp. Med. 188:1739-1750.
52. Dent, A.L., Shaffer, A.L., Yu, X., Allman, D., and Staudt, LM. 1997. Control of inflammation, cytokine expression, and germinal center formation by BCL-6. Science. 276:589-592.
53. Ye, B.H., et al. 1997. The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation. Nat. Genet. 16:161-170.
54. Dent, A.L., Hu-Li J., Paul, W.E., and Staudt, LM. 1998. T helper type 2 inflammatory disease in the absence of interleukin 4 and transcription factor STAT6. Proc. Natl. Acad. Sci. USA. 95:13823-13828.
55. Tendler, C.L., et al. 1994. Abnormal cytokine expression in Sezary and adult T-cell leukemia cells correlates with the functional diversity between these T-cell malignancies. Cancer Res. 54:4430-4435.
56. Bix, M., Wang, Z.E., Thiel, B., Schork, N.J., and Locksley, R.M. 1998. Genetic regulation of commitment to interleukin 4 production by a CD4(+) T cell-intrinsic mechanism. J. Exp. Med. 188:2289-2299.
57. Cookson, W.O.C.M., and Moffatt, M.F. 1997. Asthma: an epidemic in the absenceof infection. Science. 275:41-42.
58. Erb, K.J., Holloway, J.W., Sobeck, A., Moll, H., and Le Gros, G. 1998. Infection of mice with Mycobactenum boris-Bacillus Calmette-Guerin (BCG) suppresses allergen-induced airway eosinophilia. J. Exp. Med. 187:561-569.
59. Kline, J.N., et al. 1998. Cutting edge: modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma. J. Immunol. 160:2555-2559.
60. Robinson, D., et al. 1993. Prednisolone treatment in asthma is associated with modulation of bronchoalveolar lavage cell interleukin-4, interleukin-5, and interferon-gamma cycokine gene expression. Am. Rev. Respir Dis. 148:401-406.
61. 1 cells and IFNγ regulate allergic airway inflammaion and mucus production. In press.
62. Sur, S., et al. 1999. Long term prevention of allergic lung inflammation in a mouse model of asthma by CpG oligodeoxynucleotides. J. Immunol. 162:6284-6293.
63. Varney, V.A., et al. 1993. Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses. J. Clin. Invest. 92:644-651.
64. Holt, P.G. 1994. A potential vaccine strategy for asthma and allied atopic diseases during early childhood. Lancet. 344:456-458.